At the UF Diabetes Institute, research is one of our core missions. We know that ultimately it takes a team effort to make a difference, with families and researchers working side by side united in a common goal.
For you and your family:
Testing for autoantibodies can determine the risk of developing type 1 diabetes. UF TrialNet researchers will closely monitor people who are at moderate to high risk, and they may be eligible to participate in a prevention trial.
Currently, TrialNet has two ongoing prevention trials. Please click on the links to learn more about the Hydroxychloroquine and Abatacept studies for those at higher risk.
We need more participants. Researchers believe early treatment may help preserve the beta cell function longer.
For the type 1 diabetes community:
We are all in this together.
We know that family members are 15 times more likely to develop type 1 diabetes than the general population. In order to find treatments to prevent type 1 diabetes, we need family members to get involved.
For some, it is empowering to know that research participation may bring a better future for the type 1 diabetes community.
Using knowledge gained through clinical research, our mission is to prevent type 1 diabetes and stop disease progression by preserving insulin production before and after diagnosis.